D. Tavan

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy

C. Lambert, S. Melnikov, O. Bouché, 2021, Frontiers in Pharmacology.

Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort

I. Ray-Coquard, D. Tavan, Floriane Huet-Penz, 2022, Cancers.

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B

L. Stuyver, F. Zoulim, D. Tavan, 2000, Hepatology.

Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study

O. Bouché, N. Kerckhove, M. Selvy, 2020, Journal of clinical medicine.

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study

C. Lepage, C. Mariette, G. Piessen, 2023, Cancers.

Phase I study of daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancer.

D. Tavan, D. Pérol, M. Rivoire, 2010, International journal of radiation oncology, biology, physics.

Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life.

N. Kerckhove, M. Selvy, Coralie Gonneau, 2024, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.